Sorrento Therapeutics Inc (SRNE)

[dia76ca]

We should see these results any day now! October 2021 completion date!
THIS WILL BE BIG NEWS!
Study to Evaluate a Single Dose of STI-2020 (COVI-AMG™) in Hospitalized Adults With COVID-19

ClinicalTrials.gov Identifier: NCT04771351
Recruitment Status : Recruiting
First Posted : February 25, 2021
Last Update Posted : April 12, 2021

Brief Summary:
This is a placebo-controlled study to investigate the safety and efficacy of a single injection of COVI-AMG in inpatient adults with COVID-19.

Covid19
Biological: COVI-AMG
Drug: Placebo
Phase 2

Detailed Description:
This is a multi-center, randomized, double-blind, placebo-controlled study designed to investigate the safety and efficacy of a single injection of COVI-AMG in inpatient adults with COVID-19. Subjects will receive 100 mg of COVI-AMG, 200 mg of COVI-AMG, or placebo via slow IV push. Subjects will be followed for approximately 70 days post dosing.

Study Type : Interventional (Clinical Trial)
Estimated Enrollment : 280 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Treatment
Official Title: A Randomized, Blinded-controlled Study to Evaluate the Safety and Efficacy of a Single Dose of STI-2020 (COVI-AMG™) in Hospitalized Adult Patients With COVID-19
Estimated Study Start Date : April 2021
Estimated Primary Completion Date : August 2021
Estimated Study Completion Date : October 2021